Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $105.40 | Total: $527.00 |
| 1 | 10 | $89.28 | Total: $892.80 |
| 1 | 25 | $75.64 | Total: $1,891.00 |
| 1 | 50 | $64.48 | Total: $3,224.00 |
| 1 | 100 | $55.80 | Total: $5,580.00 |
Overview
Elsibucol (AGI 1096) is a VCAM1 inhibitor for the study of organ transplant rejection.Elsibucol is a metabolically stable propanol derivative with antioxidant, anti-inflammatory and anti-proliferative properties. It lowers blood cholesterol levels and reduces oxidative stress and inflammatory responses in injured arteries, thereby inhibiting atherosclerosis and protecting endothelial healing after arterial injury.
Chemical Properties
| Molecular Formula | C35H54O4S2 |
| Molecular Weight | 602.93 |
| CAS Numbers | 216167-95-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O(CCCC(O)=O)C1=C(C(C)(C)C)C=C(SC(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)(C)C)C=C1C(C)(C)C |
Storage and Handling
0C Short Term, -20C Long Term
References
Dussault S, et al. Elsibucol inhibits atherosclerosis following arterial injury multifunctional effects on cholesterol levels, oxidative stress and inflammation. Atherosclerosis. 2014 Nov;237[1] 194-9.